Inventor · disambiguated record
Robert J. Melder
Also filed as: MELDER ROBERT · MELDER ROBERT J
21 granted patents·16 pending applications·151 citations·filing 1997–2023
94Inventor score
Files withMEDTRONIC ARDIAN LUXEMBOURG10HUMAN GENOME SCIENCES INC9MEDTRONIC VASCULAR INC6MEDTRONIC IRELAND MFG UNLIMITED COMPANY4GEN HOSPITAL CORP2
Top patents by PatentIndex Score
37 records- 0195US7753962B2Textured medical devicesMEDTRONIC VASCULAR INC·Filed 2007·Granted Jul 13, 2010·41 cites·23 claims
- 0291US6605441B1Antibodies against fibroblast growth factor 11HUMAN GENOME SCIENCES INC·Filed 2000·Granted Aug 12, 2003·23 cites·104 claims
- 0390US11350992B2Neuromodulation and associated systems and methods for the treatment of cancerMEDTRONIC ARDIAN LUXEMBOURG·Filed 2020·Granted Jun 7, 2022·3 cites·20 claims
- 0489US11116561B2Devices, agents, and associated methods for selective modulation of renal nervesMEDTRONIC ARDIAN LUXEMBOURG·Filed 2019·Granted Sep 14, 2021·3 cites·20 claims
- 0587US6593112B1Polynucleotides encoding fibroblast growth factor 15HUMAN GENOME SCIENCES INC·Filed 2000·Granted Jul 15, 2003·11 cites·67 claims
- 0683US11304749B2Systems, devices, and associated methods for neuromodulation with enhanced nerve targetingMEDTRONIC ARDIAN LUXEMBOURG·Filed 2018·Granted Apr 19, 2022·5 cites·23 claims
- 0782US10695542B2Drug coated balloonMEDTRONIC VASCULAR INC·Filed 2017·Granted Jun 30, 2020·2 cites·19 claims
- 0882US7524501B2Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodiesHUMAN GENOME SCIENCES INC·Filed 2005·Granted Apr 28, 2009·15 cites·11 claims
- 0978US10736692B2Neuromodulation and associated systems and methods for the treatment of cancerMEDTRONIC ARDIAN LUXEMBOURG SARL·Filed 2016·Granted Aug 11, 2020·4 cites·27 claims
- 1077US7223724B1Use of vascular endothelial growth factor to treat photoreceptor cellsHUMAN GENOME SCIENCES INC·Filed 2000·Granted May 29, 2007·28 cites·20 claims
- 1176US12268438B2Systems, devices, and methods for modulating renal nerve tissueMEDTRONIC ARDIAN LUXEMBOURG·Filed 2023·Granted Apr 8, 2025·0 cites·20 claims
- 1272US8951296B2Devices and methods for photodynamically modulating neural function in a humanMEDTRONIC ARDIAN LUXEMBOURG·Filed 2013·Granted Feb 10, 2015·5 cites·24 claims
- 1371US11844568B2Systems, devices, and associated methods for neuromodulation with enhanced nerve targetingMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2022·Granted Dec 19, 2023·0 cites·22 claims
- 1469US2023329783A1Systems, devices, and associated methods for neuromodulation in heterogeneous tissue environmentsMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2023·Application pending·0 cites
- 1567US12226142B2Devices, agents, and associated methods for selective modulation of renal nervesMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2021·Granted Feb 18, 2025·0 cites·20 claims
- 1667US8678046B2Apparatus and methods for loading a drug eluting medical deviceMELDER ROBERT·Filed 2010·Granted Mar 25, 2014·7 cites·20 claims
- 1766US2022280230A1Neuromodulation and associated systems and methods for the treatment of cancerMEDTRONIC ARDIAN LUXEMBOURG·Filed 2022·Application pending·0 cites
- 1862US2020324092A1Drug coated balloonMEDTRONIC VASCULAR INC·Filed 2020·Application pending·0 cites
- 1960US2010261737A1Method of Treating Erectile DysfunctionMEDTRONIC VASCULAR INC·Filed 2009·Application pending·0 cites
- 2059US2019231420A1Systems, devices, and methods for modulating renal nerve tissueMEDTRONIC ARDIAN LUXEMBOURG·Filed 2019·Application pending·0 cites
- 2157US2004048271A1Fibroblast growth factor 11HUMAN GENOME SCIENCES INC·Filed 2003·Application pending·0 cites
- 2256US2005026838A1Fibroblast Growth Factor-13HUMAN GENOME SCIENCES INC·Filed 2004·Application pending·0 cites
- 2355US2005019824A1Fibroblast Growth Factor-10HUMAN GENOME SCIENCES INC·Filed 2004·Application pending·0 cites
- 2454US2009196900A1Use of Phosphodiesterase Inhibitor as a Component of Implantable Medical DevicesMEDTRONIC VASCULAR INC·Filed 2008·Application pending·0 cites
- 2553US8636811B2Drug eluting rolled stent and stent delivery systemMELDER ROBERT J·Filed 2010·Granted Jan 28, 2014·1 cites·14 claims
- 2653US2004043024A1Fibroblast growth factor-14HUMAN GENOME SCIENCES INC·Filed 2003·Application pending·0 cites
- 2752US11717343B2Systems, devices, and associated methods for neuromodulation in heterogeneous tissue environmentsMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2018·Granted Aug 8, 2023·0 cites·22 claims
- 2850US2010106234A1Medical Devices With Extended Drug Diffusion PathwayMEDTRONIC VASCULAR INC·Filed 2008·Application pending·0 cites
- 2950US2015133904A1Devices and Methods for Photodynamically Modulating Neural Function in a HumanMEDTRONIC ARDIAN LUXEMBOURG·Filed 2014·Application pending·0 cites
- 3048US2015327924A1Systems, devices, and methods for modulating renal nerve tissueMEDTRONIC ARDIAN LUXEMBOURG·Filed 2015·Application pending·0 cites
- 3147US2014114215A1Methods for Renal Neuromodulation and Associated Systems and DevicesMEDTRONIC ARDIAN LUXEMBOURG·Filed 2013·Application pending·0 cites
- 3246US8764777B2Endoventricular stay and delivery systemMELDER ROBERT J·Filed 2009·Granted Jul 1, 2014·0 cites·9 claims
- 3341US2011182964A1Vascular Stent Which Elutes Amino Acid-Methyl-Ester Derivatives for the Treatment of Vulnerable Plaque and Vascular DiseaseMEDTRONIC INC·Filed 2011·Application pending·0 cites
- 3438US2009317394A1Vascular endothelial growth factor-2HUMAN GENOME SCIENCES INC·Filed 2008·Application pending·0 cites
- 3536US9615948B2Drug eluting folded stent and stent delivery systemMELDER ROBERT·Filed 2010·Granted Apr 11, 2017·0 cites·27 claims
- 3622US6368858B1Modulation of multicellular aggregates by pressure from growth in a matrixGEN HOSPITAL CORP·Filed 1998·Granted Apr 9, 2002·3 cites·27 claims
- 3721US6010712ATherapeutic use of bFGF to treat conditions involving adhesion of cytotoxic white cells to endotheliumGEN HOSPITAL CORP·Filed 1997·Granted Jan 4, 2000·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Robert J. Melder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →